Palantir Technologies has shaken off last week's AI data-privacy scare with a 6.2% weekly gain to $177.64 — a meaningful reversal from the $167 trough that followed The Information's Anthropic story, and the question now is whether the analyst community's fresh conviction is finding traction.
The most notable development this week is the analyst upgrade activity, and it is genuinely bullish in direction. UBS's Karl Keirstead lifted his target to $250 from $220 on September 15 — just days after DA Davidson raised to $250 from $200. Both maintain Buy ratings. That double move, from two firms that follow the name closely, pushes the bull-camp targets well above the current price. The Street consensus is technically a Hold, and the mean price target in the system is $185 — but that figure is stale, reflecting a March snapshot, and the recent individual moves suggest active analysts have already repriced materially higher. Cantor Fitzgerald's Neutral camp is keeping a $156 target, anchoring the bear end, and the valuation math supports that caution: PLTR trades at 83x trailing earnings and 25x book. The EV/EBITDA multiple is running near 60x. These are multiples that leave no room for disappointment, which is exactly the bear case — durable commercial growth and pilot-to-production conversion remain the open questions.
Short interest is not where the drama is. Bears have been quietly retreating: SI has dropped 5.6% over the past 30 days to just under 3% of the free float, with the most recent reading at roughly 66.5 million shares. Borrowing costs are negligible at 0.35%, and the lending pool is as loose as it gets — availability is running above 8,000%, meaning for every share currently borrowed there are more than 80 available. The short score, at 32, is low and stable, barely moving across the week. Together, these readings describe a market where the short thesis is being gently unwound, not pressed — positioning looks more comfortable than contested.
Options tell a similarly benign story. The put/call ratio came in at 1.04 on Thursday, marginally below its 20-day average of 1.05, and the z-score is fractionally negative. This is not the hedged, defensive setup the options market was showing before the August earnings print. The PCR has ranged between 0.93 and 1.09 this week, close to the centre of the 52-week range of 0.61 to 1.16. There is no options signal driving urgency in either direction — the market is balanced, not braced.
The insider activity visible in the data is worth a brief note, mostly for context rather than signal. Director Alexander Moore sold approximately 16,000 shares across multiple tranches on September 15, totalling around $2.7 million — all under a pre-arranged 10b5-1 plan. Scheduled plan sales carry minimal informational weight. The 90-day net across all insiders is negative at roughly $125 million, but the bulk of that reflects CEO Alexander Karp's exercise and conversion activity, which is compensation mechanics rather than conviction selling. The institutional holder register shows BlackRock at 7.9% and Vanguard-affiliated entities in aggregate above 13%, with JP Morgan Asset Management adding over 7.7 million shares most recently — passive and index flows dominating, no activist presence.
The next earnings event is dated November 2. August's print produced a 32% single-day move and a 42% five-day move — the kind of reaction that resets the narrative entirely. Between now and then, the stock's trajectory will depend on whether the rebound from the AI-data scare can hold, and whether the $250 analyst targets from UBS and DA Davidson begin to pull the broader consensus upward. Peer performance adds texture: RBRK surged 23% on the week while PATH and SOUN slipped — suggesting the enterprise software complex is bifurcating rather than moving in tandem, which means PLTR's next move is likely to be more idiosyncratic than sector-driven.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
